Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for spontaneous passage of common bile duct stones
NL-OMON48799Phase 2Not yet recruiting
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in choledocholithiasis comparing Tamsulosin with Placebo (2 arms). Primary endpoint: Stone expulsion rate. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
tamsulosin
03
Conditions
choledocholithiasis
Beyond the preview
Go deeper on NL-OMON48799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48799.